[{"data": {"name": "How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Pat Furlong", "@type": "Person"}, {"name": "John F. P. Bridges", "@type": "Person"}, {"name": "Lawrence Charnas", "@type": "Person"}, {"name": "Justin R. Fallon", "@type": "Person"}, {"name": "Ryan Fischer", "@type": "Person"}, {"name": "Kevin M. Flanigan", "@type": "Person"}, {"name": "Timothy R. Franson", "@type": "Person"}, {"name": "Neera Gulati", "@type": "Person"}, {"name": "Craig McDonald", "@type": "Person"}, {"name": "Holly Peay", "@type": "Person"}, {"name": "H. Lee Sweeney", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-015-0281-2", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4486430?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1186/s13023-015-0281-2", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CC65t8NqnLgd6-CTLyi1Yb8DKPc-CDd4QrBxbkEM6-CRX4U5xoBc1xF", "propertyID": "ISCC"}], "datePublished": "2015-06-24"}, "schema": "schema.org", "mediatype": "application/ld+json"}]